Company: LIDRW
Filing Date: 2025-01-03
Form Type: 424B3
Source: 0000947871-25-000006
Chunk: 0

Company: AEye, Inc.
Filing Date: 2025-01-03
Form: 424B3
Chunk 0
---
Filed Pursuant to Rule 424(b)(3)

Registration No. 333-281235

PROSPECTUS SUPPLEMENT NO. 4

To Prospectus dated August 21, 2024

<div align='center'>AEYE, INC.

Up to 25,000,000 Shares of Common Stock

_________________________________</div>

This prospectus supplement (this “Supplement”)
supplements the prospectus dated August 21, 2024 (as may be supplemented from time to time, the “Prospectus”), whichis
part of a registration statement on Form S-1 (File No. 333-281235) relating to the offer and resale of up to 25,000,000 shares of common
stock of AEye, Inc. (the “Common Stock”) by New Circle Principal Investments LLC, a Delaware limited liability company (the
“Selling Stockholder” or “New Circle”). The shares of Common Stock being offered by New Circle have been and may
be issued pursuant to the share purchase agreement dated July 25, 2024 that we entered into with New Circle (the “Purchase Agreement”).
The shares registered for resale also include 225,563 shares of Common Stock that we issued to New Circle as consideration for its commitment
to purchase our Common Stock pursuant to the Purchase Agreement (the “Commitment Shares”). We are not selling any securities
under the Prospectus and will not receive any of the proceeds from the sale of our Common Stock by New Circle. However, we may receive
up to $50 million in aggregate gross proceeds from sales of our Common Stock to New Circle that we may make under the Purchase Agreement
from time to time after the date of the Prospectus. See the sections entitled “The New Circle Transaction” in the Prospectus
for a description of the transaction contemplated by the Purchase Agreement and “Selling Stockholder” in the Prospectus
for additional information regarding New Circle.

This Supplement is being filed to update and supplement
the information in the Prospectus with the information contained in the Form 8-K filed with the Securities and Exchange Commission on
January 3, 2025.

This Supplement is not complete without, and may not
be delivered or utilized except in connection with, the Prospectus. This Supplement should be read in conjunction with the Prospectus,
and if there is any inconsistency between the information in the Prospectus and this Supplement, you should rely on the information in
this Supplement.

Our registration of the